<SEC-DOCUMENT>0001213900-22-075746.txt : 20221129
<SEC-HEADER>0001213900-22-075746.hdr.sgml : 20221129
<ACCEPTANCE-DATETIME>20221129105747
ACCESSION NUMBER:		0001213900-22-075746
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20221129
DATE AS OF CHANGE:		20221129

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pasithea Therapeutics Corp.
		CENTRAL INDEX KEY:			0001841330
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				851591963
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40804
		FILM NUMBER:		221429461

	BUSINESS ADDRESS:	
		STREET 1:		2110 NARCISSUS CT
		CITY:			VENICE
		STATE:			CA
		ZIP:			90291
		BUSINESS PHONE:		8184226172

	MAIL ADDRESS:	
		STREET 1:		2110 NARCISSUS CT
		CITY:			VENICE
		STATE:			CA
		ZIP:			90291
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>ea169332-defa14a_pasitheathe.htm
<DESCRIPTION>SOLICITING MATERIAL UNDER 240.14A-12
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNITED
STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
14A INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proxy
Statement Pursuant to Section&nbsp;14(a)&nbsp;of the<BR>
Securities Exchange&nbsp;Act&nbsp;of&nbsp;1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by the
    Registrant</FONT></TD>
    <TD STYLE="width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by a party other
    than the Registrant</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Check
the appropriate box:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary Proxy Statement</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential, for Use
    of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</B></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Proxy Statement</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Additional Materials</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting Material under
    &sect; 240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PASITHEA
THERAPEUTICS CORP.<BR>
(Exact Name of Registrant as Specified In Its Charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Name
of Person(s)&nbsp;Filing Proxy Statement, if other than the Registrant)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
    of Filing Fee (Check all boxes that apply):</B></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No fee required</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee paid previously with
    preliminary materials</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee computed on table in
    exhibit required by Item&nbsp;25(b)&nbsp;per Exchange&nbsp;Act Rules 14a-6(i)(1)&nbsp;and&nbsp;0-11</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pasithea Therapeutics Postpones Special Meeting
until December 9, 2022 at 9:00 AM Eastern Time</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>MIAMI BEACH, FL, November 28, 2022</B> -
Pasithea Therapeutics Corp. (Nasdaq: KTTA) (&ldquo;Pasithea&rdquo; or the &ldquo;Company&rdquo;), a biotechnology company focused on
the discovery, research and development of innovative treatments for central nervous system (&ldquo;CNS&rdquo;) disorders, today
announced that it has postponed its Special Stockholder Meeting (the &ldquo;Special Meeting&rdquo;) originally scheduled for
November 29, 2022 to allow additional time for stockholder voting proxies (the &ldquo;Notice&rdquo;). The Special Meeting will now
be held on&nbsp;December 9, 2022&nbsp;at&nbsp;9:00 am Eastern Time&nbsp;at One Vanderbilt Avenue, 67th Floor, New York, NY 10017.
There have been no&nbsp;changes to the proposals to be voted on at the Special Meeting. The Board of Directors of the Company (the
&ldquo;Board&rdquo;) has called this Special Meeting of the Company&rsquo;s stockholders, in response to the formal request of
Concord IP2 Ltd., Elderhill Corporation, Leonite Capital LLC, Camac Partners, LLC, Leonite Fund I, LP, Camac Capital, LLC, Camac
Fund, LP, David Delaney, Avi Geller and Eric Shahinian (collectively, the &ldquo;Dissident Group&rdquo;), for stockholders to vote
on the certain proposals submitted by the Dissident Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The record date for the Special Meeting remains
November 9, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Additional Information and Where to Find It</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Special Meeting, the Company
filed a definitive proxy statement on Schedule 14A on November 15, 2022, with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;).
STOCKHOLDERS OF THE COMPANY ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT
DOCUMENTS IN CONNECTION WITH THE SPECIAL MEETING THAT THE COMPANY FILES WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN
IMPORTANT INFORMATION ABOUT THE BUSINESS TO BE CONDUCTED AT THE SPECIAL MEETING. The definitive proxy statement, and any other documents
filed by the Company with the SEC may be obtained free of charge at the SEC&rsquo;s website at www.sec.gov or at the &ldquo;Investors&rdquo;
section of our website at www.pasithea.com or by writing to our solicitor, Kingsdale Advisors, by phone toll-free at 1-866-581-1514, or
call collect outside North America at 646-854-8013, or by email at contactus@kingsdaleadvisors.com. Information about the Company&rsquo;s
directors and executive officers and their ownership of the Company securities is set forth in the Company&rsquo;s definitive proxy statement
for the Special Meeting on Schedule 14A filed with the SEC on November 15, 2022. You can obtain free copies of the definitive proxy statement
as described in the preceding paragraph.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Pasithea Therapeutics Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pasithea Therapeutics Corporation is a biotechnology company focused
on the discovery, research and development of innovative treatments for central nervous system (CNS) disorders. With an experienced team
of experts in the fields of neuroscience and psychopharmacology, Pasithea is developing new molecular entities for the treatment of neurological
disorders, including Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis, Neurofibromatosis type 1 and Noonan syndrome.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains statements that constitute
&ldquo;forward-looking statements.&rdquo; Forward-looking statements are subject to numerous conditions, many of which are beyond the
control of the Company. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed
on any such forward-looking statements, which are based on information available to the Company on the date of this release. These forward-looking
statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including, without limitation,
those set forth in the Company&rsquo;s filings with the SEC. Thus, actual results could be materially different. The Company undertakes
no obligation to update these statements whether as a result of new information, future events or otherwise, after the date of this release,
except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Company Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr. Tiago Reis Marques</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">E: tiago@pasithea.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations Contacts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lisa M. Wilson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In-Site Communications, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">T: 212-452-2793</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">E: lwilson@insitecony.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !* .8# 2(  A$! Q$!_\0
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M[BL$74'6-/-!YW$<FJOPH\'Z5X@TJ^N]5M%N LP2+=VXYK;^.'G#P[IX53Y
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
